Creative Financial Designs’s Vertex Pharmaceuticals VRTX Stock Holding History

Creative Financial Designs’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.95K	Hold	14	–	–	﹤0.01%	1619
2026 Q1	$6.25K	Hold	14	–	–	﹤0.01%	1532
2025 Q4	$6.35K	Sell	14 -7	-33%	-$3.02K	﹤0.01%	1456
2025 Q3	$8.22K	Buy	21 +6	+40%	+$2.51K	﹤0.01%	1411
2025 Q2	$6.68K	Hold	15	–	–	﹤0.01%	1449
2025 Q1	$7.27K	Buy	+15	New	+$6.99K	﹤0.01%	1377

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Creative Financial Designs's VRTX Position: Q2 2026 in Review

Creative Financial Designs held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 14 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Creative Financial Designs first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.22K in Q3 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Creative Financial Designs held 14 shares of Vertex Pharmaceuticals worth $6.95K as of Q2 2026.
Creative Financial Designs left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1619 holding.
Creative Financial Designs first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Creative Financial Designs's Vertex Pharmaceuticals position peaked at $8.22K in Q3 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.